October 2019 updates include announcement of IDG expansion with associated R03 awardees; new Target Watch in Nature Reviews Drug Discovery; and information on upcoming outreach events with opportunities for real life IDG updates. 

Expansion of IDG associations

Early fall, NIH announced awardees of the first round of R03's for 'Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases' . There are 16 of them!  You can find them listed on NIH's IDG Common Fund site. We are excited and eager to hear of their progress as these awardees join us in future meetings.

Please note that NIH have reissued this R03 call. So check out RFA-RM-19-011 for more information.

Target Watch in NRDD

The new IDG Target Watch in Nature Reviews Drug Discovery draws on information from the DRGC-Kinase group's Dark Kinase Knowledgebase:

  • ADCK3/COQ8A: the choice target of the UbiB protein kinase-like family - link to article

Upcoming Outreach Events

Here are a few upcoming opportunities for hearing about outcomes from IDG.

  • Dr. Bryan Roth (UNC, DRGC-GPCR) will be giving the Schoolar Lecture at Baylor College of Medicine in Houston, TX on October 26, 2019.
  • The top performers of the IDG-DREAM Drug-Kinase Binding Prediction Challenge will present at RECOMB/ISCB RSG conference held in New York City, NY on Nov. 4-6, 2019.
  • Workshop by Tim Sheils (NCATS, KMC) and Dr. Tudor Oprea on IDG PHAROS will be given in the Unilever Lecture Theatre, Department of Chemistry, on Lensfield Road (CB2 1EW), starting at 1 pm on November 14, 2019. Attendees should email Andreas Bender at until 8 November if they wish to attend.
  • Dr. Tudor Oprea (UNM, KMC-UNM and RDOC-UNM) will be presenting at an EMBL Conference 'Expanding the Druggable Proteome with Chemical Biology' taking place at EMBL Heidelberg, Germany on February 5-7, 2020. Click here for more information.
We are also happy to announce an upcoming IDG Outreach meeting taking place in Chapel Hill, NC on May 4-5, 2020 with invited speakers and IDG speakers. Further details will be covered in future IDG Newsletters.

Find us online

DRGC: U24 DK116195, U24 DK116204, U24 DK116214
KMC: U24 CA224370, U24 CA224260;  RDOC: U24 TR002278
CEIT: U01 CA239106, U01 CA239108, U01 CA239069
More IDG details on our IDG site or via NIH Common Fund site.
DruggableGenome Twitter DruggableGenome Twitter
Pharos Twitter Pharos Twitter
view this email in your browser
Copyright © 2019, RDOC part of IDG, All rights reserved.
IDG Newsletter Vol. 4, 2019-10-01

Our email address is:

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
Illuminating the Druggable Genome · 1 University of New Mexico · Albuquerque, NM 87131-0001 · USA

Email Marketing Powered by Mailchimp